Provided by Tiger Trade Technology Pte. Ltd.

Oculis

9.91
-0.1600-1.59%
Post-market: 9.71-0.2000-2.02%19:30 EDT
Volume:314.10K
Turnover:3.09M
Market Cap:611.76M
PE:-5.78
High:10.20
Open:10.11
Low:9.65
Close:10.07
52wk High:34.48
52wk Low:9.65
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.80
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.30
PE(LYR):-4.15

Loading ...

Oculis Holding AG Phase 3 Trial of Potential Eye Drops for Diabetic Patients Fails to Primary Endpoint

MT Newswires Live
·
May 30

Oculis reports primary endpoint of DIAMOND Phase 3 trials was not met

TIPRANKS
·
May 30

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

GlobeNewswire
·
May 30

Oculis Holding AG trading halted, news pending

TIPRANKS
·
May 30

NASDAQ TRADE HALT HALT NEWS PENDING AT 02:43 PM

Reuters
·
May 30

Oculis quickly falls 26% to $22 per share

TIPRANKS
·
May 30

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
May 29

Oculis Holding Initiated at Buy by Guggenheim

Dow Jones
·
May 21

Guggenheim Initiates Oculis Holding at Buy With $75 Price Target

MT Newswires Live
·
May 21

Oculis initiated with a Buy at Guggenheim

TIPRANKS
·
May 21

Fujian Aims for Over 300 Billion Yuan in Photonics Cluster Revenue by 2030, Accelerates R&D on High-Speed Optical Modules

Deep News
·
May 19

Oculis Holding Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 18

Oculis Holding (OCS) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 16

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
May 16

Oculis AGM Backs All Proposals, Adds Veteran Biotech CFO to Board and Expands Capital Flexibility

TIPRANKS
·
May 15

Press Release: Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors

Dow Jones
·
May 15

Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 13

Stock Track | Oculis Holding Plummets 5.05% Intraday Following Analyst Ratings

Stock Track
·
May 12

Oculis price target raised to $44 from $43 at BofA

TIPRANKS
·
May 12

Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Apogee Therapeutics (APGE)

TIPRANKS
·
May 12